Conference abstract · 5 Dec 2018
Conference abstract
Innovation in method development; Drugs solubility and stability during bioanalysis process
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The stability of a drug, metabolite, or any chemical agent during the development of the bioanalytical procedure, is essential for method validation. Some drugs are critically unstable and other groups of important drug agents are either insoluble or less soluble in the aqueous matrix. Innovative research in this area is needed to assure drug stability and solubility during the entire analysis process. This work not only eases the validation process, but also assures the accuracy and precision of the final data. The stock solution of the analyte should be confirmed for complete solubility, storage condition and stability, similarly, working standard solutions which are lower in concentration. Stock solution stability is demonstrated by preparing a fresh solution from the reference material and comparing the absolute response of the fresh solution with that of the stored solution. In that study sample results are directly influenced by analyte stock solutions. It is recommended that the acceptable difference between the absolute responses of fresh stock solutions and the aged stock solutions be tighter (within 2%-5%) than that normally applied to the bioanalytical results (ie, within 15%-20%). The stability of the drug in the spiked matrix during the sample preparation or extraction is key to the successful analytical method used for the less stable analyte and related metabolites. Methods for drugs such as Omeprazole and UC-781 will be presented. Chromatographic-based assays mostly use internal standards. Compounds used as internal standards should be stable and soluble. The analyte of interest and the method internal standard must be reliable and behave similarly during sample prep, extraction, and analysis.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 16 Oct 2017
Hot-Melt Extrusion: A cost effective approach leading to enhancement of bioavailability and acceleration of drug product development process via turning poorly water soluble drugs into viable therapeutics
Research article · 19 Jun 2023
An Innovative Stability-Indicating Liquid Chromatography with Tandem Mass Spectrometry Method Development and Validation for the Determination of Sotorasib in Human Plasma
Research article · 23 Mar 2012
DEVELOPMENT AND VALIDATION OF A NEW STABILITY INDICATING HPLC METHOD FOR QUANTIFICATION OF PROCESS RELATED AND DEGRADATION IMPURITIES OF BICALUTAMIDE IN TABLET DOSAGE FORMS
Commentary · 16 Feb 2022
Stability Testing and its Role in Drug Development Process
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Article · 5 Oct 2026
Long COVID in pediatric and young adult patients: a review of evaluation for microvascular changes, endothelial dysfunction, and arterial stiffness
Article · 12 Jun 2026
Advances in Bioavailability Through Innovative Drug Delivery Systems and Formulation Technologies
Article · 12 Jun 2026
Bioequivalence Study Design and Methodological Approaches in Generic Drug Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Naser L. Rezk”
